Related Experiment Video
Updated: Feb 28, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Evaluation of Microorganisms Causing Ventilator-Associated Pneumonia in a Pediatric Intensive Care Unit
Ayse Betul Ergul1, Serife Cetin2, Yasemin Ay Altintop3
1Department of Pediatrics, Kayseri Training and Research Hospital, Kayseri, Turkey.
Objective:
The aim of this study was to identify microorganisms causing ventilator-associated pneumonia (VAP) and also study the antibiotic resistance/susceptibility.
Materials And Methods:
We retrospectively assessed microorganisms isolated from patients diagnosed with VAP in a pediatric intensive care unit between January 1, 2014, and June 30, 2016.
Results:
We included 44 patients diagnosed with VAP. The prevalence thereof was 8.6 patients per 1,000 ventilator days. Mechanical ventilation was required for 56.5% of patients. Thirty-three patients (75%) died. An underlying chronic disease was detected in 75% of patients (n=33). Fifty microorganisms were isolated from 44 patients. Single microorganisms were isolated from 86.4% (n=38) and two from 13.6% (n=6) of patients. Of all the isolated bacteria, 96% (n=48) were gram-negative; the most common was Pseudomonas aeruginosa (32%), followed by Klebsiella pneumoniae (24%) and Acinetobacter baumannii (22%). The isolates were most susceptible to colistin (92.6%), followed by piperacillin-tazobactam (71.4%), amikacin (65.2%), and gentamicin (52.2%). No enterobacterium or Acinetobacter strain was resistant to colistin; however, 13% of P. aeruginosa isolates were resistant.
Conclusion:
In VAP, it is essential to catalog antibiotic resistance patterns of bacteria present in the unit to ensure that empirical antibiotic therapy is effective.
Insights
This study identified common bacteria causing ventilator-associated pneumonia (VAP) in a pediatric ICU. Colistin showed high susceptibility, but resistance in Pseudomonas aeruginosa highlights the need for local antibiotic resistance monitoring.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Ventilator-associated pneumonia (VAP) is a significant concern in pediatric intensive care units (PICUs).
- Understanding the causative microorganisms and their antibiotic susceptibility is crucial for effective treatment.
Purpose of the Study:
- To identify the microorganisms responsible for VAP in a PICU.
- To assess the antibiotic resistance and susceptibility patterns of these VAP-causing pathogens.
Main Methods:
- Retrospective analysis of VAP cases in a PICU from January 2014 to June 2016.
- Identification and antibiotic susceptibility testing of isolated microorganisms from VAP patients.
Main Results:
- 44 VAP patients were included; 75% had underlying chronic diseases and 75% mortality.
- Gram-negative bacteria predominated (96%), with Pseudomonas aeruginosa (32%), Klebsiella pneumoniae (24%), and Acinetobacter baumannii (22%) being most common.
- High susceptibility was observed for colistin (92.6%), piperacillin-tazobactam (71.4%), amikacin (65.2%), and gentamicin (52.2%).
Conclusions:
- Local antibiotic resistance patterns are essential for guiding empirical antibiotic therapy in VAP.
- Colistin remains effective against most VAP pathogens, but monitoring resistance in P. aeruginosa is necessary.
More Related Videos
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Pneumonia II: Pathophysiology